These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 32119835)

  • 1. Predictive value of insulin-like growth factor 1-Child-Turcotte-Pugh score for mortality in patients with decompensated cirrhosis.
    Yao Y; Yang D; Huang Y; Dong M
    Clin Chim Acta; 2020 Jun; 505():141-147. PubMed ID: 32119835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting Mortality Across a Broad Spectrum of Liver Disease-An Assessment of Model for End-Stage Liver Disease (MELD), Child-Turcotte-Pugh (CTP), and Creatinine-Modified CTP Scores.
    Chawla YK; Kashinath RC; Duseja A; Dhiman RK
    J Clin Exp Hepatol; 2011 Dec; 1(3):161-8. PubMed ID: 25755381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis.
    Huo TI; Lin HC; Wu JC; Lee FY; Hou MC; Lee PC; Chang FY; Lee SD
    Liver Transpl; 2006 Jan; 12(1):65-71. PubMed ID: 16382473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of the prognostic value of mortality Child Pugh Score and forecasting models of chronic liver disease in patients with decompensated cirrhosis of the Hospital Nacional Cayetano Heredia, Lima-Peru].
    Valenzuela Granados V; Salazar-Quiñones M; Cheng-Zárate L; Malpica-Castillo A; Huerta Mercado J; Ticse R
    Rev Gastroenterol Peru; 2015; 35(4):307-12. PubMed ID: 26802883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of model for end-stage liver disease and Child-Turcotte-Pugh scores over time in evaluating the prognosis of patients with decompensated cirrhosis: experience in the Chinese mainland.
    Bie CQ; Yang DH; Tang SH; Huang W
    Hepatol Res; 2009 Aug; 39(8):779-85. PubMed ID: 19473429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model for End stage Liver Disease (MELD) and Child-Turcotte-Pugh (CTP) scores: Ability to predict mortality and removal from liver transplantation waiting list due to poor medical conditions.
    Rahimi-Dehkordi N; Nourijelyani K; Nasiri-Tousi M; Ghodssi-Ghassemabadi R; Azmoudeh-Ardalan F; Nedjat S
    Arch Iran Med; 2014 Feb; 17(2):118-21. PubMed ID: 24527973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of insulin-like growth factor-1 as a prognostic parameter in patients with hepatocellular carcinoma in a European cohort.
    Huber Y; Bierling F; Labenz C; Koch S; Schmidtmann I; Kloeckner R; Schotten S; Huber T; Lang H; Woerns MA; Galle PR; Weinmann A; Weinmann-Menke J
    BMC Cancer; 2018 Jul; 18(1):774. PubMed ID: 30064393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The prognostic value of end-stage liver disease model in liver cirrhosis].
    Zhang JY; Zhang FK; Wang BE; Jia JD; Zhang ST
    Zhonghua Nei Ke Za Zhi; 2005 Nov; 44(11):822-4. PubMed ID: 16316560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the ability of the PDD-ICG clearance test, CTP, MELD, and MELD-Na to predict short-term and medium-term mortality in patients with decompensated hepatitis B cirrhosis.
    Cheng XP; Zhao J; Chen Y; Meng FK; Xu B; Yu HW; Meng QH; Liu YM; Zhang SB; Meng S; Zhang JY; Zhang JY; Duan ZP; Zheng SJ
    Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):444-8. PubMed ID: 26649802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Child-Turcotte-Pugh versus model for end stage liver disease score for predicting survival in hospitalized patients with decompensated cirrhosis.
    Chaurasia RK; Pradhan B; Chaudhary S; Jha SM
    J Nepal Health Res Counc; 2013 Jan; 11(23):9-16. PubMed ID: 23787518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of mortality in cirrhotic patients undergoing extrahepatic surgery: comparison of Child-Turcotte-Pugh and model for end-stage liver disease-based indices.
    Kim DH; Kim SH; Kim KS; Lee WJ; Kim NK; Noh SH; Kim CB
    ANZ J Surg; 2014 Nov; 84(11):832-6. PubMed ID: 23647879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does adding variceal status to the Child-Turcotte-Pugh score improve its performance in predicting mortality in cirrhosis?
    Fan X; Wen M; Shen Y; Wang W; Yang X; Yang L
    Medicine (Baltimore); 2016 Sep; 95(38):e4884. PubMed ID: 27661030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Creatinine-modified Child-Turcotte-Pugh score is a good predictor of a short-term survival in patients with bleeding from esophageal varices.
    Radisavljević M; Bjelaković G; Jović J; Radovanović-Dinić B; Benedoto-Stojanov D; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2017 Jan; 74(1):13-8. PubMed ID: 29350501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of creatinine-modified Child Pugh score for predicting short-term prognosis of patients with decompensated cirrhosis of liver as compare to original child Pugh score.
    Samiullah S; Qasim R; Khalid S; Hussain BG; Mukhtair J; Akbar Y
    J Ayub Med Coll Abbottabad; 2009; 21(2):64-7. PubMed ID: 20524472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scoring systems for prediction of mortality in decompensated liver cirrhosis: A meta-analysis of test accuracy.
    Wu SL; Zheng YX; Tian ZW; Chen MS; Tan HZ
    World J Clin Cases; 2018 Dec; 6(15):995-1006. PubMed ID: 30568954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical value of Child-Turcotte-Pugh and model for end-stage liver disease score to predict the prognosis of chronic severe hepatitis].
    Jiang ZS; Jiang JN
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):412-5. PubMed ID: 17631709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a Modified Child-Turcotte-Pugh Classification System Utilizing Insulin-Like Growth Factor-1 for Patients with Hepatocellular Carcinoma in an HBV Endemic Area.
    Lee DH; Lee JH; Jung YJ; Gim J; Kim W; Kim BG; Lee KL; Cho Y; Yoo JJ; Lee M; Cho YY; Cho EJ; Yu SJ; Kim YJ; Yoon JH
    PLoS One; 2017; 12(1):e0170394. PubMed ID: 28107416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation.
    Gotthardt D; Weiss KH; Baumgärtner M; Zahn A; Stremmel W; Schmidt J; Bruckner T; Sauer P
    BMC Gastroenterol; 2009 Sep; 9():72. PubMed ID: 19778459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of insulin-like growth factor-1 score to assess hepatic reserve in hepatocellular carcinoma.
    Kaseb AO; Xiao L; Hassan MM; Chae YK; Lee JS; Vauthey JN; Krishnan S; Cheung S; Hassabo HM; Aloia T; Conrad C; Curley SA; Vierling JM; Jalal P; Raghav K; Wallace M; Rashid A; Abbruzzese JL; Wolff RA; Morris JS
    J Natl Cancer Inst; 2014 May; 106(5):. PubMed ID: 24815863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of model for end-stage liver disease score with discriminant function and child-Turcotte-Pugh scores for predicting short-term mortality in Korean patients with alcoholic hepatitis].
    Jeong JY; Sohn JH; Son BK; Paik CH; Kim SH; Han DS; Jeon YC; Lee MH; Lee DH; Kee CS
    Korean J Gastroenterol; 2007 Feb; 49(2):93-9. PubMed ID: 17322788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.